Pak No. 7, 8 & 9
Natural health product licensed in Canada
- Other names
- Tablet No. 7, 8, 9 Beige, Universal Nutrition Animal Pak Tablet No. 789
- Licence holder
- Universal Nutrition
- NPN or DIN-HM
- 80088654
- Status
- Active licence
- Licence date
- 11 October 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Triacylglycérol lipase Source : Triacylglycerol lipase | 2,000 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 1.67 mg | Not calculated |
| Concentré de protéine de lactosérum Source : Bos taurus - Lait Potency : 80 % Whey protein | 100 mg | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique, dihydraté | 46.24 mg | 138,720 µg |
| Bêta-carotène Source : bêta-carotène Potency : 1,641.33 UI | 4.92 mcg | Not calculated |
| Papaïne Source : Carica papaya - fruit | 10.67 mg | Not calculated |
| Phosphore Source : Ammonium phosphate-dibasic | 35.18 mg | 105,540 µg |
| Vitamine A Source : Acétate de vitamine A Potency : 82.67 UI | 0.167 mg RAE | Not calculated |
| Vitamine D Source : Vitamin D Potency : 46.67 UI | 1.17 mcg | 3.51 µg |
| Mélange de caroténoïdes Source : Mixed carotenoids | 128.33 mcg | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 21,340 Unité de pepsine du FCC | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau, Maltodextrine, Glaçure pharmaceutique, Cellulose microcristalline, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Contains digestive enzymes Helps to maintain eyesight Helps to maintain skin membranes Helps to maintain immune function Helps in the development and maintenance of night vision Helps in the development and maintenance of bones and teeth Helps to prevent Vitamin A deficiency contains provitamin A for the maintenance of good health and to help maintain eyesight, skin, membranes and immune function Helps in the absorption and use of calcium and phosphorus Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use If you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato), consult a health care practitioner prior to use Consult a health care practitioner prior to use if you are a tobacco smoker
- Contre-indications
If you have a milk allergy, do not use this product
Source
Official Health Canada record, licence 80088654
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.